If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Eiichi Ogawa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Chronic Hepatitis C Medicine & Life Sciences
Ribavirin Medicine & Life Sciences
Hepacivirus Medicine & Life Sciences
Genotype Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences
Interferons Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients with genotype 2 chronic hepatitis C: An analysis with real world outcomes from a multicentre cohort in Japan

Igarashi, A., Furusyo, N., Ogawa, E., Nomura, H., Dohmen, K., Higashi, N., Takahashi, K., Kawano, A., Azuma, K., Satoh, T., Nakamuta, M., Koyanagi, T., Kato, M., Shimoda, S., Kajiwara, E. & Hayashi, J., Jun 1 2019, In : BMJ open. 9, 6, e023405.

Research output: Contribution to journalArticle

Open Access
Ribavirin
Chronic Hepatitis C
Cost-Benefit Analysis
Japan
Genotype
3 Citations (Scopus)

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study

The Kyushu University Liver Disease Study (KULDS) Group, Jun 1 2019, In : Hepatology Research. 49, 6, p. 617-626 10 p.

Research output: Contribution to journalArticle

Chronic Hepatitis C
Cohort Studies
Genotype
Infection
Antiviral Agents
8 Citations (Scopus)

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis

Li, J., Zou, B., Yeo, Y. H., Feng, Y., Xie, X., Lee, D. H., Fujii, H., Wu, Y., Kam, L. Y., Ji, F., Li, X., Chien, N., Wei, M., Ogawa, E., Zhao, C., Wu, X., Stave, C. D., Henry, L., Barnett, S., Takahashi, H. & 12 others, Furusyo, N., Eguchi, Y., Hsu, Y. C., Lee, T. Y., Ren, W., Qin, C., Jun, D. W., Toyoda, H., Wong, V. W. S., Cheung, R., Zhu, Q. & Nguyen, M. H., May 1 2019, In : The Lancet Gastroenterology and Hepatology. 4, 5, p. 389-398 10 p.

Research output: Contribution to journalArticle

Meta-Analysis
Incidence
Hepatocellular Carcinoma
Non-alcoholic Fatty Liver Disease
Liver Diseases
Virus Diseases
Hepatitis B virus
HIV
Hepatitis B Surface Antigens
DNA
3 Citations (Scopus)

Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: A systematic review and meta-analysis

Ji, F., Yeo, Y. H., Wei, M. T., Ogawa, E., Enomoto, M., Lee, D. H., Iio, E., Lubel, J., Wang, W., Wei, B., Ide, T., Preda, C. M., Conti, F., Minami, T., Bielen, R., Sezaki, H., Barone, M., Kolly, P., Chu, P. S., Virlogeux, V. & 15 others, Eurich, D., Henry, L., Bass, M. B., Kanai, T., Dang, S., Li, Z., Dufour, J. F., Zoulim, F., Andreone, P., Cheung, R. C., Tanaka, Y., Furusyo, N., Toyoda, H., Tamori, A. & Nguyen, M. H., Sep 1 2019, In : Journal of Hepatology. 71, 3, p. 473-485 13 p.

Research output: Contribution to journalArticle

Chronic Hepatitis C
Antiviral Agents
Meta-Analysis
Hepatocellular Carcinoma
Therapeutics